The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial

समान संसाधन

• The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
  द्वारा: Anne Wajja, और अन्य
  प्रकाशित: (2017-05-01)
• Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
  द्वारा: Wajja, A, और अन्य
  प्रकाशित: (2018)
• Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
  द्वारा: Wajja, A, और अन्य
  प्रकाशित: (2024)
• Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A [version 1; referees: 1 approved, 2 approved with reservations]
  द्वारा: Anne Wajja, और अन्य
  प्रकाशित: (2018-09-01)
• Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial
  द्वारा: Wajja, A, और अन्य
  प्रकाशित: (2023)